Author

Ernest M. Kameni

Indiana University Indianapolis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Patrice Nsangou MimcheiD· 2 shared Amav Khambete· 1 shared Anna E. BeaudiniD· 1 shared Brian P Krum· 1 shared Clint H. Valencia· 1 shared Daniel S Barrera· 1 shared Estelle Atiogue· 1 shared Francis Sprouse· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Patrice Nsangou MimcheORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 31, 2026

Developmental IL7/IL7R signaling in fetal resident tissue macrophages regulates adaptive responses to liver injury

Nicole Tseng, Gabriel Leung, Brian P Krum…·Anna E. Beaudin

This study shows that IL7/IL7R signaling during fetal development programs liver-resident macrophages, which are critical for postnatal immune responses to liver injury.

DOI 10.64898/2026.10.26.761961

mousebulk RNA-seq

𝕏 PostBluesky

PathologybioRxivPreprintNov 19, 2025

Diet-induced MASH liver fibrosis promoted by EphB2 can be targeted by small molecule tetramerization inhibitors

Masaaki Yoshigi, Séverin Donald Kamdem, Hanghang Wang…·Patrice Nsangou Mimche

This study identifies EphB2 as a driver of MASH liver fibrosis and shows that targeting EphB2 with small molecule inhibitors can reduce fibrosis in mouse models.

DOI 10.1101/2025.11.19.688968

mousehuman

𝕏 PostBluesky